Finally, the immunohistochemical staining results in the tumor tissue of cHL patients showed that the positive rates of PD-1 and PD-L1 were higher in the tumor tissue of cHL patients, which may be one of the factors contributing to the better efficacy of PD-1 monoclonal antibodies in HL patients. The gene discussed is PDCD1; the disease is Hodgkins lymphoma.